Lab Notes: Penn Medicine’s $14M NIH grant; NRx seeks designation for drug candidate

Philadelphia-area life sciences news this week includes updates on research on how to use CAR T-cell therapy to help kidney transplant patients, breakthrough therapy designation request for a drug candidate, and a drug for relapsed or refractory multiple myeloma patients.
Click here to view original post